CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4/A Returned to the company 10% owner returned 869,565 shares (to the company)
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Agreement ended · Auditor change
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 4 Conversion 10% owner acquired 27,250 shares (conversion)
- 4 Returned to the company 10% owner returned 869,565 shares (to the company)
- 25-NSE Other Notification of Removal from Listing
- 25-NSE Other Notification of Removal from Listing
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 17 of 24 · 479 filings